1. Editorial

   • Michael D. Walker

   EditorialNotes Pages: 97 - 98

2. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features

   • Diana F Nelson
   • James S. Nelson
   • Thomas F. Pajak

   OriginalPaper Pages: 99 - 103

3. Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors

   • F. Cohadon
   • N. Aouad
   • J. F. Dartigues

   OriginalPaper Pages: 105 - 111

4. Penetration of hematoporphyrin derivative into rat brain and intracerebral 9L glioma tissue

   • Donald PJ
   • Boisvert John DS McKean
   • Man-Kai Cheng

   OriginalPaper Pages: 113 - 118

5. Central nervous system pharmacokinetics of high-dose cytosine arabinoside

   • Jose A. Lopez
   • Edgard Nassif
   • Ram P. Agarwal

   OriginalPaper Pages: 119 - 124

6. Interferon-β in patients with low-grade astrocytomas — A phase I study

   • U. Bogdahn
   • B. Fleischer
   • H. Przuntek

   OriginalPaper Pages: 125 - 130

7. Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group study

   • Sarah A Taylor
   • Joseph D McCracken
   • Barbara A Neilan

   OriginalPaper Pages: 131 - 135

8. Differentiation markers (S-100, GFAP, NSE and D2) in fetal rat brain cells during malignant transformation in cell culture

   • O. D. Laerum
   • S. J. Mørk
   • K. Haglid

   OriginalPaper Pages: 137 - 146

9. Chemotherapy trials in recurrent primary intracranial germ cell tumors

   • Jeffrey C. Allen
   • Georges Bosl
   • Russell Walker

   OriginalPaper Pages: 147 - 152

10. Apparent glucose utilization in Walker 256 metastatic brain tumors

    • Ronald G Blasberg
    • Mami Shinohara
    • Joseph D. Fenstermacher

    OriginalPaper Pages: 153 - 164

11. The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology

    • J. A. Garson
    • H. B. Coakham
    • S. Bourne

    OriginalPaper Pages: 165 - 171

12. Cross-reactivity between human hemopoietic cells and brain tumors as defined by monoclonal antibodies

    • Herbert Budka
    • Otto Majdic
    • Walter Knapp

    OriginalPaper Pages: 173 - 179

13. Immunolocalization of monoclonal antibody-defined extracellular matrix antigens in human brain tumors

    • Rodney D. McComb
    • Darell D. Bigner

    OriginalPaper Pages: 181 - 186

14. Delayed adverse effects after irradiation of gliomas: clinicopathological analysis

    • Riccardo Soffietti
    • Rossella Sciolla
    • Davide Schiffer

    OriginalPaper Pages: 187 - 192

15. Announcements

    Announcement Pages: 193 - 193